BOD Science
- Short interest
- 0.00%
- 0.00 pp 30d
- as of 24 Oct 2023
- Reported shorts
- 1.7K
- Shares on issue
- 177.339M
BOD Science (BOD) Short Interest
BOD Science (ASX:BOD) had 0.00% of shares reported as short positions as of 24 Oct 2023, representing 1,681 shares. BOD Science operates in the Consumer Discretionary Distribution & Retail industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4About BOD Science
Bod Science Limited (ASX:BOD) is a global life science healthcare company specializing in cannabis-centric products and solutions. The company is dedicated to innovating and transforming lives by delivering premium, proven, and trusted cannabinoid-based medications. It actively engages in clinical research, such as the CAN-REST study for insomnia, and provides comprehensive resources for accessing medicinal cannabis and informing both consumers and medical professionals.
Company profile →BOD Science (ASX:BOD) has 0.00% of its shares on issue reported as short positions as of 24 Oct 2023, or about 1,681 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. BOD is classified in the Consumer Discretionary Distribution & Retail industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Short interest
History & FAQ →Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.
Latest BOD news
All news- What Is Putting Bod Australia (ASX:BOD) Back in Focus?
kalkine · 31 July 2026
- Removal from Official List
asx · 30 Nov 2025
- Letter to Shareholders
asx · 24 Nov 2025
Company details
More Consumer Discretionary Distribution & Retail Stocks
Other shorted stocks in this sector
Be the first to discuss BOD
Start a research thread or post the first pulse update